956229-86-0

Basic information

• Product Name: Methyl 2-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate
• Synonyms: 2-(Methoxycarbonylmethyl)phenylboronic acid pinacol ester;Methyl 2-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate;methyl 2-[2-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetate;2-(2-Methoxy-2-oxoethyl)benzeneboronicacid,pinacolester96%;Methyl [2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetate
• CAS NO: 956229-86-0
• Molecular Formula: C₁₅H₂₁BO₄
• Molecular Weight: 276.13584
• Mol File: 956229-86-0.mol

Chemical Properties

• Melting Point: 66-68 °C
• Boiling Point: 371.7±25.0 °C(Predicted)
• Appearance: /
• Density: 1.07±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Methyl 2-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 2-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate(956229-86-0)
• EPA Substance Registry System: Methyl 2-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate(956229-86-0)

Safety Data

• Hazardous Substances Data: 956229-86-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 2-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure and reactivity enable the development of new drugs with improved efficacy and safety profiles.
Used in Agrochemical Industry:
In the agrochemical sector, Methyl 2-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate serves as a crucial component in the production of pesticides and other agrochemicals. Its incorporation into these products enhances their effectiveness in protecting crops and controlling pests.
Used in Perfume and Fragrance Industry:
Methyl 2-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate is utilized as a raw material in the creation of perfumes and fragrances. Its distinctive chemical properties contribute to the development of unique and complex scents, enriching the olfactory experience.
Used as a Reagent in Chemical Reactions:
Methyl 2-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate is employed as a reagent in a variety of chemical reactions, including cross-coupling and Suzuki-Miyaura reactions. Its mild reactivity allows for the formation of new chemical bonds with high selectivity and efficiency, facilitating the synthesis of complex organic molecules for various applications.

Upstream product

• 57486-69-8 methyl 2-(2-bromophenyl)acetate 
• 73183-34-3 bis(pinacol)diborane 
• 18698-97-0 ortho-bromophenylacetic acid 
• 55116-09-1 2-bromophenylacetyl chloride 

Downstream Products

• 154191-77-2 methyl <2-(2-thienyl)phenyl>acetate 
• 1421438-81-4 LY3039478 
• 19206-51-0 2-(2-hydroxyethyl)benzene boronic acid cyclic monoester 

Relevant articles and documents

LIPOXYGENASE INHIBITORS

Various embodiments of the present disclosure are directed to compounds having Formula I, Formula II, Formula IIA, Formula III, Formula IIIA, Formula IIIB, and/or pharmaceutically acceptable salts thereof. The compounds can be suitable for inhibiting lipoxygenases and/or treating associated diseases. In some embodiments, subject compounds are used to prepare a composition that is effective in treating neurodegenerative diseases.

Internal Nucleophilic Catalyst Mediated Cyclisation/Ring Expansion Cascades for the Synthesis of Medium-Sized Lactones and Lactams

A strategy for the synthesis of medium-sized lactones and lactams from linear precursors is described in which an amine acts as an internal nucleophilic catalyst to facilitate a novel cyclisation/ring expansion cascade sequence. This method obviates the n

TARGETED TREATMENT OF LEIOMYOSARCOMA

A method and medicament comprising 4,4,4-trifluoro-N-[(1S)-2-[[(7S)-5-(2- hydroxyethyl)-6-oxo-7H-pyrido[2,3-d][3]benzazepin-7-yl]amino]-1-methyl-2-oxo- ethyl]butanamide or a pharmaceutically acceptable salt or hydrate thereof for treating leiomyosarcoma i

PHOTOCHROMIC THIENOCHROMENE COMPOUNDS

The present invention relates to photochromic compounds, such as thienochromene compounds represented by the following Formulas (la) and/or (lb). The present invention also relates to photochromic compositions and articles containing one or more such phot

NOTCH PATHWAY SIGNALING INHIBITOR COMPOUND

The present invention provides a compound, or a pharmaceutically acceptable salt or hydrate, and a pharmaceutical composition containing said compound, or a pharmaceutically acceptable salt or hydrate, useful as a Notch pathway signaling inhibitor for the

One-pot synthesis of new aza- and diaza-aminophenanthrenes

The synthesis of a series of benzo(iso)quinoline and phenanthroline derivatives has been achieved using an efficient one-pot procedure. It proceeds through a Suzuki-Miyaura cross-coupling followed by a Dieckmann-Thorpe ring closure under microwave irradia

One-pot synthesis of novel poly-substituted phenanthrenes

A one-pot synthesis of novel poly-substituted phenanthrenes is described in this article through a Suzuki-Miyaura cross-coupling followed by a Dieckmann-Thorpe ring closure under microwave irradiation. The selection of the appropriate starting materials allowed us to introduce diversity on various positions of the phenanthrene ring system.

PHENANTHRENE DERIVATIVES AS MPGES-1 INHIBITORS

The invention encompasses novel compounds of Formula or pharmaceutically acceptable salts thereof. These compounds are inhibitors of the microsomal prostaglandin E synthase-1 (mPGES-1) enzyme and are therefore useful to treat pain and/or inflammation from a variety of diseases or conditions, such as osteoarthritis, rheumatoid arthritis and acute or chronic pain. Methods of treating diseases or conditions mediated by the mPGES-1 enzyme and pharmacuetical compositions are also encompassed